Associations Between Bipolar Disorder and Metabolic Syndrome: A Review
The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To examine the pathophysiologic mechanisms that may link bipolar disorder and metabolic syndrome and to discuss whether the consequences of metabolic syndrome underlie a substantive portion of the premature morbidity and mortality observed in persons with bipolar disorder. DATA SOURCES: A MEDLINE search, citing articles from 1966 onward, supplemented by a review of bibliographies, was conducted to identify relevant studies. Bipolar disorder, mood disorder, metabolic syndrome, diabetes, cardiovascular illness, and obesity were used as keywords. Criteria used to select studies included (1) English language, (2) published studies with original data in peer-reviewed journals, and (3) studies that confirmed the nature of the mood disorder examined. RESULTS: Ninety-seven studies met criteria and were reviewed for evidence of dysregulation in various physiologic systems. Bipolar disorder and metabolic syndrome share features of hormonal, immunologic, and autonomic nervous system dysregulation. CONCLUSION: Lifestyle features may account, in part, for the premature mortality observed in bipolar disorder, but the somatic correlates of the illness may also predispose patients to metabolic syndrome and the consequent increased risk of diseases such as diabetes and vascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“metabolic syndrome not only greatly increases an individual's risk for cardiovascular disease, diabetes mellitus, and premature mortality779 but also worsens bipolar clinical outcomes.780, 781”
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Actual Causes of Death in the United States, 2000
Mokdad, A. H. (2004) · JAMA · doi:10.1001/jama.291.10.1238 · Cited by 5,211
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Physical Activity, All-Cause Mortality, and Longevity of College Alumni
Paffenbarger, R. S., Hyde, R., Wing, A. L., & Hsieh, C.-C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198603063141003 · Cited by 2,742
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationComorbidities and Mortality in Bipolar Disorder: A Swedish National Cohort Study
Crump, C., Sundquist, K., Winkleby, M. A., & Sundquist, J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1394 · Cited by 677
Vancampfort, D., Vansteelandt, K., Correll, C. U., Mitchell, A. J., De Herdt, A., Sienaert, P., Probst, M., & De Hert, M. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12050620 · Cited by 441
An overview of links between obesity and mental health
Avila, C., Holloway, A. C., Hahn, M. K., Morrison, K. M., Restivo, M., Anglin, R., & Taylor, V. H. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0164-9 · Cited by 366
Self-citationPremature Mortality From General Medical Illnesses Among Persons With Bipolar Disorder: A Review
Roshanaei-Moghaddam, B., & Katon, W. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.2.147 · Cited by 305
Laursen, T. M., Munk-Olsen, T., Agerbo, E., Gasse, C., & Mortensen, P. B. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.61 · Cited by 271
Wasan, K. M., Brocks, D. R., Lee, S. D., Sachs-Barrable, K., & Thornton, S. J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2353 · Cited by 269
Integrated Neurobiology of Bipolar Disorder
Maletic, V., & Raison, C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00098 · Cited by 226
“Combined with autonomic disturbance, increased platelet/endothelial aggregation and unhealthful lifestyle, elevated inflammation may contribute to substantially increased risk of respiratory and gastrointestinal disorders, cerebrovascular and cardiovascular disease, and migraines in the bipolar population (79, 168, 20…”
BackgroundWon, E., & Kim, Y.-K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122679 · Cited by 223
“Alterations in HPA axis function in BD include excess corticotropin-releasing factor (CRF) and adrenocorticotropic hormone (ACTH) secretion, which ultimately increase cortisol levels [135].”
BackgroundBipolar disorder and metabolic syndrome: An international perspective
McIntyre, R. S., Danilewitz, M., Liauw, S. S., Kemp, D. E., Nguyen, H. T. T., Kahn, L. S., Kucyi, A., Soczynska, J. K., Woldeyohannes, H. O., Lachowski, A., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.012 · Cited by 213
“immuno-inflammatory) risk factors is apparent in the BD population (McIntyre et al., 2007; Taylor and Macqueen, 2006) (See Fig.”
BackgroundInfluentialSelf-citationRobinson, D. J., Coons, M., Haensel, H., Vallis, M., & Yale, J.-F. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.031 · Cited by 209
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L., Macek, T. A., & Panagides, J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00748.x · Cited by 189
“Patients with bipolar disorder tend to have a higher prevalence of obesity and related comorbidities such as diabetes mellitus (45, 46).”
BackgroundResultBipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers
Muneer, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.18 · Cited by 187
Barry, D., Pietrzak, R. H., & Petry, N. M. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.12.009 · Cited by 184
Bipolar Disorder: New Perspectives in Health Care and Prevention
Leboyer, M., & Kupfer, D. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06347yel · Cited by 176
“such as smoking (70% of outpatients with bipolar disorder are nicotine dependent), alcoholism, poor diet, and sedentary lifestyle.(48) In the STEP-BD program, substance abuse and smoking were found to be associated with more lifetime mood episodes and greater severity of symptoms, as well as rapid cycling, comorbid ps…”
BackgroundThe Salted Food Addiction Hypothesis may explain overeating and the obesity epidemic
Cocores, J. A., & Gold, M. S. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.06.049 · Cited by 171
“eatery, being entertained, from 5 PM until 12 M on weekdays, and when celebrating (1) Obesity [96] (2) Sedentary lifestyle [97] (3) Mood disorders [98] (4) Sleep and awakening disturbances [99] (5) Attention deficit disorder [100] (6) Bulimic symptoms [101]”
BackgroundMood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus
Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S., Alsuwaidan, M., Yim, C. Y., & McIntyre, R. S. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 164
“Studies with rodents have also demonstrated that glu- cocorticoids diminish leptin signals, providing support for the hypothesis that HPA-axis may be associated with obesity via inefficient leptin signaling (Taylor and Macqueen 2006; Zakrzewska et al. 1997).”
Zuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157
“Individuals with BPD present a higher incidence of metabolic syndrome in comparison to the general population (Fagiolini et al., 2005; Taylor and MacQueen, 2006; Garcia-Portilla et al., 2008).”
BackgroundMedical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems
SayuriYamagata, A., Brietzke, E. M., Rosenblat, J. D., Kakar, R., & McIntyre, R. S. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.12.059 · Cited by 175
“Dysregulation of the hypothalamus-pituitary-adrenal (HPA) axis is frequent in BD (Taylor and MacQueen, 2006).”
BackgroundMedical comorbidity in bipolar disorder: reprioritizing unmet needs
McIntyre, R. S., Soczynska, J. K., Beyer, J. L., Woldeyohannes, H. O., Law, C. W., Miranda, A., Konarski, J. Z., & Kennedy, S. H. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281938102 · Cited by 140
Robinson, D. J., Luthra, M., & Vallis, M. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.026 · Cited by 160
Fagiolini, A. M., Chengappa, K. N. R., Soreca, I., & Chang, J. P. (2008) · CNS Drugs · doi:10.2165/00023210-200822080-00004 · Cited by 138
Prevalence of metabolic syndrome among Australians with severe mental illness
John, A. P., Koloth, R., Dragovic, M., & Lim, S. C. B. (2009) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02342.x · Cited by 129
Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap
McIntyre, R. S., Rasgon, N. L., Kemp, D. E., Nguyen, H. T., Law, C. W. Y., Taylor, V. H., Woldeyohannes, H. O., Alsuwaidan, M. T., Soczynska, J. K., Kim, B., et al. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0010-0 · Cited by 127
“During the past decade, several clinical studies have provided empirical evidence to buttress these earlier clinical observations reporting higher age-adjusted MeS rates among individuals with schizophrenia and bipolar disorder [ 8 ,9].”
ResultSelf-citationBartoli, F., Carrà, G., Crocamo, C., Carretta, D., & Clerici, M. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0010 · Cited by 95
“17 Some reviews have analyzed the relationship between metabolic syndrome and severe mental disorders, such as schizophrenia, 18 bipolar disorder, 19 and depression.”
The impact of mental illness on cardiac outcomes: A review for the cardiologist
Sowden, G. L., & Huffman, J. C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.10.002 · Cited by 97
“Among persons with psychiatric illness, there is a higher prevalence of unhealthy behaviors and known CVD risk factors, such as smoking, alcohol misuse, obesity, sedentary lifestyle, hypertension, diabetes, poor diet and poor treatment compliance [81,92–101].”
BackgroundInvolvement of IL-1β in acute stress-induced worsening of cerebral ischaemia in rats
Caso, J. R., Moro, M. A., Lorenzo, P., Lizasoain, I., & Leza, J. C. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.009 · Cited by 84
Bipolar Disorder and Metabolic Syndrome: A Systematic Review
Czepielewski, L., Filho, L. D., Brietzke, E., & Grassi-Oliveira, R. (2013) · Revista Brasileira de Psiquiatria · doi:10.1016/j.rbp.2012.07.004 · Cited by 81
Ramsey, C. M., Leoutsakos, J.-M., Mayer, L. S., Eaton, W. W., & Lee, H. B. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.024 · Cited by 78
“Cross-sectionally, studies based on clinical samples have reported that BPD patients have high prevalence of CVD risk factors such as metabolic syndrome, obesity, hypertension, high cholesterol, diabetes, and smoking (Kilbourne, et al, 2004; Newcomer, 2004; Taylor and MacQueen, 2006).”
High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan
Chang, H. H., Chou, C. H., Chen, P. S., Gean, P. W., Huang, H. C., Lin, C. Y., Yang, Y. K., & Lu, R. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.018 · Cited by 82
Predicting Mood Changes in Bipolar Disorder Through Heartbeat Nonlinear Dynamics
Valenza, G., Nardelli, M., Lanata, A., Gentili, C., Bertschy, G., Kosel, M., & Scilingo, E. P. (2016) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2016.2554546 · Cited by 69
“According to this classification, the diagnosis of depressive episodes is made if the patient exhibits 5 out of 9 possible symptoms.”
MethodEnhanced cancer risk among patients with bipolar disorder
Barchana, M., Levav, I., Lipshitz, I., Pugachova, I., Kohn, R., Weizman, A., & Grinshpoon, A. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.09.003 · Cited by 69
“, 2006), the metabolic syndrome (Cowey and Hardy, 2006; Taylor and MacQueen, 2006), high rate of smoking (Waxmonsky et al.”
BackgroundMetabolic Syndrome and Bipolar Disorder: What Should Psychiatrists Know?
de Almeida, K. M., Moreira, C. L. R. L., & Lafer, B. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00240.x · Cited by 64
“biological correlates of these conditions [40].”
BackgroundInfluentialHealth and Economic Burden of Metabolic Comorbidity Among Individuals With Bipolar Disorder
Centorrino, F., Mark, T. L., Talamo, A., Oh, K., & Chang, J. P. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181bef8a6 · Cited by 70
Kerman, I. A., Bernard, R., Bunney, W. E., Jones, E. G., Schatzberg, A. F., Myers, R. M., Barchas, J. D., Akil, H., Watson, S. J., & Thompson, R. C. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00135 · Cited by 59
“…of 16%, MDD is characterized by a high burden of morbidity caused by co-occurrence of physical ailments together with a high level of mortality due to suicide (Carney et al., 1993; Frank and Thase, 1999; Penninx et al., 2001; Kessler et al., 2003; Brown et al., 2004; Taylor and MacQueen, 2006).”
BackgroundMetabolic Syndrome in a Workplace: Prevalence, Co-Morbidities, and Economic Impact
Schultz, A. B., & Edington, D. W. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0008 · Cited by 71
“44,45 The results shown in Fig.”
Elmslie, J. L., Porter, R., Joyce, P. R., Hunt, P. J., Shand, B. I., & Scott, R. S. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802534341 · Cited by 59
“Psychotropic medication may also exacerbate this risk [14,15], with the common end-point being obesity.”
BackgroundMoreno, C., Merchán‐Naranjo, J., Álvarez, M., Baeza, I., Alda, J. A., Martínez‐Cantarero, C., Parellada, M., Sánchez, B., De La Serna, E., Giráldez, M., et al. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00797.x · Cited by 54
Šilarova, B., Giltay, E. J., Dortland, A. K. B. V. R., van Rossum, E. F. C., Hoencamp, E., Penninx, B. W. J. H., & Spijker, A. T. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.02.010 · Cited by 60
“Additionally, physical inactivity and poor dietary habits have been reported in BD and are associated with weight gain and obesity [31].”
BackgroundInfluentialMetabolic Syndrome in Bipolar Disorders
Grover, S., Malhotra, N., Chakrabarti, S., & Kulhara, P. (2012) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.101767 · Cited by 48
“[7,8] There is some evidence to suggest that metabolic disturbances and obesity are associated with a disease course, which is worse and are likely to contribute to the premature mortality in BPAD.[9,10] Metabolic disturbances have also been associated with treatment non-adherence and higher treatment costs.”
BackgroundMood disorders: A potential link between ghrelin and leptin on human body?
Zarouna, S., Wozniak, G., & Papachristou, A. I. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i2.103 · Cited by 56
Age‐specific prevalence of metabolic syndrome in Italian patients with bipolar disorder
Salvi, V., D'Ambrosio, V., Rosso, G., Bogetto, F., & Maina, G. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02160.x · Cited by 47
Callaghan, R. C., & Khizar, A. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.029 · Cited by 52
Sex differences in rates of obesity in bipolar disorder: postulated mechanisms
Baskaran, A., Cha, D. S., Powell, A. M., Jalil, D., & McIntyre, R. S. (2013) · Bipolar Disorders · doi:10.1111/bdi.12141 · Cited by 49
“The excess rate of CVD in BD is due to the clustering of both traditional Bipolar Disorders 2014: 16: 83–92 © 2013 John Wiley & Sons A/S Published by John Wiley & Sons Ltd. BIPOLAR DISORDERS (e.g., obesity) and emerging (e.g., inflammation) risk factors for CVD (4).”
BackgroundInfluentialMcIntyre, R. S., Alsuwaidan, M., Goldstein, B. I., Taylor, V. H., Schaffer, A., Beaulieu, S., & Kemp, D. E. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400108 · Cited by 45
Self-citationDepp, C. A., Ojeda, V. D., Mastin, W., Unützer, J., & Gilmer, T. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.10.1169 · Cited by 43
Suppes, T. M., McElroy, S. L., PhD, McElroy, S. L., MD, Hirschfeld, A. R., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4119 · Cited by 43
Ayuso‐Mateos, J. L., Ávila, C. C., Anaya, C., Cieza, A., Vieta, E., & and the Bipolar Disorders Core Sets Expert Group (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2013.771708 · Cited by 49
“Diabetes mellitus and metabolic syndrome are other physical correlations found that need to be taken into account [60,61].”
BackgroundLee, S.-Y., Chen, S.-L., Chang, Y.-H., Chen, P. S., Huang, S.-Y., Tzeng, N.-S., Wang, Y.-S., Wang, L.-J., Lee, I. H., Wang, T.-Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066847 · Cited by 40
Clinical Trial of Wellness Training: Health Promotion for Severely Mentally Ill Adults
Chafetz, L., White, M., Collins-Bride, G., Cooper, B. A., & Nickens, J. (2008) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e31817738de · Cited by 41
“These studies show similar excess prevalence for diabetes, and a burgeoning literature on metabolic syndrome indicates broader risk (Lamberti et al., 2006; McEvoy et al., 2005; Taylor and MacQueen, 2006).”
BackgroundReproductive and Metabolic Abnormalities Associated with Bipolar Disorder and Its Treatment
Kenna, H. A., Jiang, B., & Rasgon, N. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902899722 · Cited by 43
Increased risk of gout among patients with bipolar disorder: A nationwide population-based study
Chung, K., Huang, C., & Lin, H. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.07.012 · Cited by 39
“However, uric acid, the final product of purine nucleotides metabolism, having been reported as a marker of increased cardiovascular risk (Taylor and MacQueen, 2006), has not been adequately studied in bipolar disorder.”
BackgroundPhysical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder
Subramaniapillai, M., Arbour‐Nicitopoulos, K. P., Duncan, M. J., McIntyre, R. S., Mansur, R. B., Remington, G. J., & Faulkner, G. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2151-y · Cited by 51
The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder
McIntyre, R. S., Woldeyohannes, H. O., Soczynska, J. K., Miranda, A., Lachowski, A. M., Liauw, S. S. L., Grossman, T., Lourenço, M. T. C., Kim, B., Alsuwaidan, M. T., et al. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0072-z · Cited by 39
“In keeping with the NCEP ATP III definition, we defined the MeS component criteria as: ( 1 ) abdominal obesity: waist circumference >102 cm (40 inches) in men and >88 cm (35 inches) in women; (2) high blood pressure >130/>85 mmHg; (3) hypertriglyceridemia ≥150 mg/dL (≥1.69 mmol/L); (4) low HDL-C ≤40 mg/dL (≤1.04 mmol/…”
MethodInfluentialGomes, F. A., Almeida, K. M., Magalhães, P. V., Caetano, S. C., Kauer-Sant'Anna, M., Lafer, B., & Kapczinski, F. (2013) · Revista Brasileira de Psiquiatria · doi:10.1590/1516-4446-2011-0768 · Cited by 35
Associations Between Components of Metabolic Syndrome and Cognition in Patients With Schizophrenia
S. GOUGHARI, A., MAZHARI, S., POURRAHIMI, A. M., SADEGHI, M. M., & NAKHAEE, N. (2015) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000065 · Cited by 35
“complete the cognitive tests; (5) stable dose of primary typical or atypical antipsychotic for at least 4 weeks; (6) no physical health problem requiring frequent changes in medications; and (7) capacity and willingness to give written informed consent.”
BackgroundLin, C.-Y., Sawa, A., & Jaaro-Peled, H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.025 · Cited by 37
“However, considering the high prevalence of metabolic disturbances in SCZ (McEvoy et al., 2005) and BPD (Taylor and MacQueen, 2006), these models will be very useful and provide us with valuable information especially when their behavioral and neurochemical changes are examined in the light of…”
Bauer, M., Lecrubier, Y., & Suppes, T. M. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.10.007 · Cited by 35
“Many medications used to treat bipolar disorder are associated with adverse effect (AE) profiles that may initiate or worsen metabolic abnormalities [7,24,38,41], although varied effects have been observed.”
BackgroundMetabolic syndrome among psychiatric outpatients with mood and anxiety disorders
Hung, C., Liu, C.-Y., Hsiao, M., Yu, N., & Chu, C. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-185 · Cited by 39
“Moreover, other factors might also have an impact on MetS, such as lifestyle and shared features of hormonal, immunologic, and autonomic nervous system dysregulation between mental disorders and MetS [5,11,12].”
BackgroundYamagata, A. S., Mansur, R. B., Rizzo, L. B., Rosenstock, T. R., McIntyre, R. S., & Brietzke, E. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.010 · Cited by 33
“…changes ave been implicated in mood disorders including but not being estricted to chronic low grade inflammation, thyroid dysfunction, ypothalamus-Pituitary-Adrenal (HPA) axis reprogramming and etabolic syndrome (MetS) (Czepielewski et al., 2013; Liu et al., 014; Taylor and MacQueen, 2006).”
Thermenos, H. W., Makris, N., Whitfield, S., Brown, A., Giuliano, A. J., Lee, E. H., Faraone, S. V., Tsuang, M. T., & Seidman, L. J. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00920.x · Cited by 34
Aripiprazole for the maintenance treatment of bipolar I disorder: A review
McIntyre, R. S. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.01.022 · Cited by 32
Treatment of bipolar disorder: New perspectives
Alda, M., Hájek, T., Calkin, C., & O’Donovan, C. (2008) · Annals of Medicine · doi:10.1080/07853890802409489 · Cited by 35
“It is not clear whether this increase in CV risk factors is related to treatment, life-style, socio-economic status, presence of atypical depressive symptoms (hypersomnia and hyperphagia with carbohydrate craving), endocrine dysregulation (hypercortisolemia), immunological effects (overexpression of inflammatory marke…”
BackgroundMagnavita, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130944 · Cited by 32
“Psychological disorders such as depression and anxiety have consistently been reported to be associated with MES [2–4]).”
BackgroundGuan, N., Liu, H., Diao, F., Zhang, J., Zhang, M., & Wu, T. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02150.x · Cited by 29
Frequency of metabolic syndrome and its associated factors in health care workers
Niazi, E., Saraei, M., Aminian, O., & Izadi, N. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.10.013 · Cited by 38
White matter hyperintensities – from medical comorbidities to bipolar disorders and back
Gunde, E., Blagdon, R. A., & Hájek, T. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.595733 · Cited by 30
GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective
Carmellini, P., Cuomo, A., Rescalli, M. B., & Fagiolini, A. M. (2025) · Life · doi:10.3390/life15091422 · Cited by 30
“Patients with BD and comorbid IR or type 2 diabetes are more likely to experience rapid cycling, a chronic course of illness, and poor response to lithium or other mood stabilizers [34,46].”
Bipolar disorder and leisure-time physical activity: Results from a national survey of Canadians
Cairney, J., Veldhuizen, S., Faulkner, G., Schaffer, A., & Rodriguez, M. C. (2009) · Mental health and physical activity · doi:10.1016/j.mhpa.2009.09.003 · Cited by 30
Effect of obesity on cognition in adults with and without a mood disorder: study design and methods
Restivo, M. R., McKinnon, M. C., Frey, B. N., Hall, G. B., & Taylor, V. H. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009347 · Cited by 34
“manifest as cognitive decline, as a consequence of this associated weight gain.(37) 38 Given that a strong association between cognitive impairment and poor psycho-”
BackgroundSelf-citationCastellini, G., Lapi, F., Ravaldi, C., Vannacci, A., Rotella, C. M., Faravelli, C., & Ricca, V. (2008) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.01.005 · Cited by 24
“005 in overweight clinical samples is relevant [12,13], and different studies suggested that depressive symptoms are positively associated with obesity level in treatment-seeking obese samples [14-19].”
BackgroundChang, H. H., Chen, P. S., Cheng, Y. W., Wang, T., Yang, Y. K., & Lu, R. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx093 · Cited by 25
“In addition, epidemiologic evidence has indicated increased metabolic abnormalities in BD patients, with a prevalence of metabolic syndrome of 30% to 50% (Taylor and MacQueen, 2006; Chang et al., 2009).”
BackgroundLin, H., Tsai, S., & Lee, H. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31815c1e93 · Cited by 24
“The association between somatic risk factors and bipolar disorder is considered to predispose bipolar patients to an increased risk of vascular disease (8,9).”
BackgroundRasgon, N., Kenna, H. A., Reynolds-May, M. F., Stemmle, P. G., Vemuri, M., Marsh, W., Wang, P. W., & Ketter, T. A. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00839.x · Cited by 23
“The dysfunction in the hypothalamic-pituitary-adrenal axis may lead to elevated levels of leptin and increased adipose tissue, which could in turn result in obesity (33).”
BackgroundPrevalence of metabolic syndrome in bipolar disorder: An exploratory study from North India
Grover, S., Aggarwal, M., Chakrabarti, S., Dutt, A., Avasthi, A., Kulhara, P., Malhotra, N., Somaiya, M. P., & Chauhan, N. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.10.013 · Cited by 23
Toward stratified treatments for bipolar disorders
Hasler, G., & Wolf, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.12.006 · Cited by 30
“The main reason for this excess mortality is thought to be the high comorbidity with somatic diseases: up to 80% of bipolar patients also suffer from metabolic and/or cardiovascular disease (Swartz and Fagiolini, 2012; Taylor and MacQueen, 2006).”
BackgroundMetabolic syndrome and depressive symptoms among rural Northeast general population in China
Yu, S., Yang, H., Guo, X., Zheng, L., & Sun, Y. (2017) · BMC Public Health · doi:10.1186/s12889-016-3913-0 · Cited by 25
Personalized and precision medicine as informants for treatment management of bipolar disorder
Perugi, G., Rossi, P. D., Fagiolini, A. M., Girardi, P., Maina, G., Sani, G., & Serretti, A. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000260 · Cited by 33
“In addition to increased appetite and reduced energy expenditure, poor sleep and circadian rhythms dysregulation may play an important role (Taylor and MacQueen, 2006).”
BackgroundIn vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism
Cikánková, T., Fišar, Z., & Hroudová, J. (2019) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01791-3 · Cited by 24
Genetic overlap between polycystic ovary syndrome and bipolar disorder: The endophenotype hypothesis
Jiang, B., Kenna, H. A., & Rasgon, N. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.056 · Cited by 25
“Increased glucose tolerance and insulin resistance are more common in BD patients than the general population [172].”
BackgroundA UK consensus on the administration of aripiprazole for the treatment of mania
Aitchison, K. J., Bienroth, M., Cookson, J., Gray, R. J., Haddad, P. M., Moore, B. A., Ratna, L., Sullivan, G., Taylor, D. M., Taylor, M., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108098820 · Cited by 23
“Bipolar patients in North America are estimated to have three times the rate of diabetes in comparison with the general population (McIntyre, et al., 2005b) and a high incidence of metabolic syndrome (Taylor and MacQueen, 2006) and other cardiovascular risk factors (McIntyre, et al., 2007).”
BackgroundConcurrent medical conditions with pediatric bipolar disorder
Scheffer, R. E., & Linden, S. C. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3281a305c3 · Cited by 19
Risk of hypertension in patients with bipolar disorder in Taiwan: A population-based study
Chien, I., Lin, C.-H., Chou, Y., & Chou, P. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.01.004 · Cited by 19
“In general, bipolar patients have early onset of symptoms during their adolescence or young adulthood, and they receive psychotropic medications such as mood stabilizer, antipsychotic, or antidepressant from the initial stage of the disease, which makes them prone to development of hypertension at a younger age compar…”
BackgroundInfluentialAsenapine for bipolar disorder
Sajatovic, M., Scheidemantel, T., Korobkova, I., & Rej, S. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s78043 · Cited by 19
“Metabolic parameters BD and metabolic syndrome share features of hormonal, immunologic, and autonomic nervous system dysregulation which can make patients more vulnerable to increased risk of metabolic syndrome, diabetes, and vascular disease.(37) A meta-analysis of 37 studies (N=6,983) concluded that 37.”
BackgroundMaripuu, M., Wikgren, M., Karling, P., Adolfsson, R., & Norrback, K. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.024 · Cited by 24
“…low socioeconomic status and the side effects of drugs may contribute to the increase in CVD risk factors and CVD, more research is needed that examines the fundamental biological link between affective disorders and CVD not mediated through the above mentioned factors (Taylor and MacQueen, 2006).”
Prevalence of Prediabetes and Diabetes Mellitus Type II in Bipolar Disorder
Kittel‐Schneider, S., Bury, D., Leopold, K., Haack, S., Bauer, M., Pfeiffer, S., Sauer, C., Pfennig, A., Völzke, H., Grabe, H. J., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00314 · Cited by 20
Chi, M. H., Chang, H. H., Tzeng, N., Huang, S., Chou, K., Tsai, H. C., Yang, Y. K., Lu, R., & Chen, P. S. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.042 · Cited by 20
Fitzgerald, P. J. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.01.018 · Cited by 20
“dysregulation [57].”
Huang, J., Berkovitch, S. S., Iaconelli, J., Watmuff, B., Park, H., Chattopadhyay, S., McPhie, D. L., Öngür, D., Cohen, B. M., Clish, C. B., et al. (2016) · Complex Psychiatry · doi:10.1159/000446654 · Cited by 20
Arterial Stiffness in Patients Taking Second-generation Antipsychotics
Fındıklı, E., Gökçe, M., Nacitarhan, V., Camkurt, M. A., Fındıklı, H. A., Kardaş, S., Şahin, M. C., & Karaaslan, M. F. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.4.365 · Cited by 19
Lee, S. Y., Chen, S., Chang, Y., Chen, P.-S., Huang, S., Tzeng, N., Wang, C.-L., Wang, L.-J., Lee, I., Wang, T., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12324 · Cited by 15
“Patients with BD have a higher prevalence rate of metabolic syndrome than does the general population (32).”
BackgroundGutiérrez-Rojas, L., Perea, J. R. A., Bernardo, M., Rojo, L., Mesa, F., & Martínez-Ortega, J. M. (2014) · Actas Españolas de Psiquiatría · Cited by 27
Guerdjikova, A. I., McElroy, S. L., Kotwal, R., Stanford, K. E., & Keck, P. E. (2006) · Eating Behaviors · doi:10.1016/j.eatbeh.2006.11.001 · Cited by 13
Cultural diversity in physical diseases among patients with mental illnesses
Larsen, J. I., Andersen, U. A., Becker, T. M., Bickel, G. G., Bork, B., Cordes, J., Frasch, K., Jacobsen, B. A., Jensen, S. O. W., Kilian, R., et al. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412463614 · Cited by 15
“Bipolar disorder-like depression has been found to be associated with an increased risk of metabolic syndrome, where both lifestyle and the disorder itself may account for premature mortality (Taylor and MacQueen, 2006).”
BackgroundOral, E., Halıcı, Z., Çınar, İ., Ozcan, E., & Kutlu, Z. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.2.211 · Cited by 12
Maina, G., & Ripellino, C. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.943732 · Cited by 13
“Some studies also suggest that lipid profiles may be negatively affected by AAs [5,6].”
InfluentialMetabolic syndrome in patients with severe mental illness in Gorgan
Marjani, A., Kamkar, M., Sanagoo, A., Zargarani, F., & Jouybari, L. M. (2016) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.175073 · Cited by 17
“Elevated mortality is reported from psychiatric disorders such as schizoaffective, bipolar, and depressive disorders.[43-45] In our study, the prevalence of metabolic syndrome was lower than some other studies in patients with bipolar disorder and psychotic depression.”
ResultFagiolini, A. M., Forgione, R. N., Morana, B., Maccari, M., Goracci, A., Bossini, L., Pellegrini, F., Cuomo, A., & Casamassima, F. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.765859 · Cited by 12
“However, olanzapine is associated with severe metabolic consequences in the long term [51,52], whereas asenapine exhibited a lower risk of metabolic side effects.”
BackgroundBohman, H., Agartz, I., Mansouri, S., Naessén, T., & Lundberg, M. (2020) · Brain and Behavior · doi:10.1002/brb3.1862 · Cited by 12
“Research over several decades have shown a connection between pharmacological therapy for psychotic and bipolar disorders and development of risk markers for CVD (Correll et al., 2009; Newcomer, 2006; Taylor & Macqueen, 2006).”
BackgroundHigher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar Disorder
Mohite, S., Wu, H., Sharma, S., Lavagnino, L., Zeni, C., Currie, T. T., Soares, J. C., & Pigott, T. A. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.2.279 · Cited by 12
“Reviews by Taylor and MacQueen [13], Fagiolini et al. [14] addressed the common pathophysiological link between BD and MetS through several mechanisms, namely-dysregulations in glucose, insulin, hemostasis, sympathetic nervous system, and disturbances in the hypothalamic-pituitary-adrenal and the hypothalamic-pituitar…”
Method
Metadata
- Authors
- Taylor, V., & MacQueen, G.
- Affiliations
- McMaster University (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-07-15
- Volume
- 67
- Issue
- 07
- Pages
- 1034-1041
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2081622818
- Cited by
- 152
- References
- 102
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 5 · 2016: 13 · 2015: 10 · 2014: 7 · 2013: 15 · 2012: 12
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- bipolar disorder, metabolic syndrome, diabetes mellitus, cardiovascular disease, obesity, hormonal dysregulation, immune dysregulation, autonomic dysfunction, premature mortality, lifestyle factors, pathophysiology
- MeSH terms
- Bipolar Disorder, Cardiovascular Diseases, Diabetes Mellitus, Humans, Hydrocortisone, Life Style, Mortality, Obesity, Psychotropic Drugs, Risk Factors, Stress, Psychological, Comorbidity, Cytokines, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.